Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2006-12-25
pubmed:abstractText
We retrospectively investigated the clinical characteristics of human herpesvirus 6 (HHV-6) meningoencephalitis within 100 days after allogeneic hematopoietic stem cell transplantation (HSCT). Of 1148 patients who received transplants between January 1999 and December 2003, 11 patients (0.96%) with HHV-6 meningoencephalitis were identified. Ten of 11 recipients received hematopoietic stem cells from donors other than HLA-identical siblings. Confusion was the most frequent central nervous system (CNS) symptom, and a skin rash with high-grade fever preceded the CNS symptoms in 9 patients. Magnetic resonance imaging of the brain showed an abnormal increased T2 signal in the hypothalamus of 5 patients. Eight patients were treated with ganciclovir, and an improvement of CNS symptoms was obtained in 3 patients; 3 patients treated with acyclovir showed no improvement. Improvement in the meningoencephalitis seemed less frequent in patients with abnormal findings in the hypothalamus than in those without such findings. Because the symptoms of HHV-6 meningoencephalitis mimicked those of cyclosporine- or tacrolimus-induced encephalopathy, the drugs were withdrawn at the onset of CNS symptoms in 10 patients, resulting in the development of grade IV graft-versus-host disease (GVHD) in 5 patients. Three patients died of HHV-6 meningoencephalitis, and 6 died of other causes, including GVHD. In conclusion, HHV-6 meningoencephalitis is a rare but potentially life-threatening complication in patients who undergo allogeneic HSCT. Careful assessment of the clinical findings and the brain may allow early and precise diagnosis of HHV-6 meningoencephalitis and contribute to improving its prognosis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0925-5710
pubmed:author
pubmed:issnType
Print
pubmed:volume
84
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
432-7
pubmed:meshHeading
pubmed-meshheading:17189225-Adolescent, pubmed-meshheading:17189225-Adult, pubmed-meshheading:17189225-Aged, pubmed-meshheading:17189225-Antiviral Agents, pubmed-meshheading:17189225-Child, pubmed-meshheading:17189225-Female, pubmed-meshheading:17189225-Ganciclovir, pubmed-meshheading:17189225-Graft vs Host Disease, pubmed-meshheading:17189225-Hematologic Neoplasms, pubmed-meshheading:17189225-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:17189225-Herpesvirus 6, Human, pubmed-meshheading:17189225-Humans, pubmed-meshheading:17189225-Hypothalamus, pubmed-meshheading:17189225-Magnetic Resonance Imaging, pubmed-meshheading:17189225-Male, pubmed-meshheading:17189225-Meningoencephalitis, pubmed-meshheading:17189225-Middle Aged, pubmed-meshheading:17189225-Prognosis, pubmed-meshheading:17189225-Retrospective Studies, pubmed-meshheading:17189225-Roseolovirus Infections, pubmed-meshheading:17189225-Transplantation, Homologous
pubmed:year
2006
pubmed:articleTitle
Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients.
pubmed:affiliation
Department of Internal Medicine and Clinical Immunology, Yokohama City University, Graduate School of Medicine, Yokohama, Japan. kfujimaki@cancer.livedoor.com
pubmed:publicationType
Journal Article